Filana Therapeutics, Inc. (FLNA) Tops Q2 EPS by 3c

Filana Therapeutics, Inc. (NASDAQ: FLNA) reported Q2 EPS of ($0.18), $0.03 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Filana Therapeutics, Inc. (FLNA) click here.

You May Also Be Interested In

• Active options: NVDA TSLA SPCX MU AAPL INTC CRWV
• Ross Stores (ROST) call put ratio 7.4 calls to 1 put with a focus on August 14 weekly 260 and June 280 calls
• United States Antimony (UAMY) April 14 weekly options active as share price down 25%